Janine Elson

TL;DR: The guideline provides clinicians with clear advice on best practice in RPL, based on the best evidence available, and is approved by the guideline group and the ESHRE Executive Committee.

TL;DR: Pragmatic ANXA5 M5 screening and treatment with LMWH in couples undergoing IVF is associated with similar outcome to couples with more favorable prognostic factors, and LMWH treatment should be started prior to clinical pregnancy.

TL;DR: This work responds to the comments made in the BBC commissioned article by Heneghan and colleagues and the Panorama programme by Deborah Cohen about pre-implantation genetic screening (PGS), which was among the three “add on” treatments highlighted in the programme and the 41 listed in the article.

TL;DR: The inconsistent effectiveness of low-molecular-weight heparin (LMWH) treatment in trials may be lack of stratification as result of inclusion of heterogeneous disease mechanisms rather than focusing on procoagulant mechanisms.

TL;DR: This information is intended to help clarify the aims and objectives of the proposed £20m fund-raising campaign and assist with the selection of suitable donors.